Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma

A total of 206 women were followed for a minimum of 5 years after primary melanoma surgery to establish if hormone replacement therapy (HRT) adversely affected prognosis. In all, 123 had no HRT and 22 have died of melanoma; 83 had HRT for varying periods and one has died of melanoma. After controlli...

Descripción completa

Detalles Bibliográficos
Autores principales: MacKie, R M, Bray, C A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410176/
https://www.ncbi.nlm.nih.gov/pubmed/14970851
http://dx.doi.org/10.1038/sj.bjc.6601595
_version_ 1782155946422697984
author MacKie, R M
Bray, C A
author_facet MacKie, R M
Bray, C A
author_sort MacKie, R M
collection PubMed
description A total of 206 women were followed for a minimum of 5 years after primary melanoma surgery to establish if hormone replacement therapy (HRT) adversely affected prognosis. In all, 123 had no HRT and 22 have died of melanoma; 83 had HRT for varying periods and one has died of melanoma. After controlling for known prognostic factors, we conclude that HRT after melanoma does not adversely affect prognosis.
format Text
id pubmed-2410176
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-24101762009-09-10 Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma MacKie, R M Bray, C A Br J Cancer Short Communication A total of 206 women were followed for a minimum of 5 years after primary melanoma surgery to establish if hormone replacement therapy (HRT) adversely affected prognosis. In all, 123 had no HRT and 22 have died of melanoma; 83 had HRT for varying periods and one has died of melanoma. After controlling for known prognostic factors, we conclude that HRT after melanoma does not adversely affect prognosis. Nature Publishing Group 2004-02-23 2004-02-17 /pmc/articles/PMC2410176/ /pubmed/14970851 http://dx.doi.org/10.1038/sj.bjc.6601595 Text en Copyright © 2004 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Short Communication
MacKie, R M
Bray, C A
Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma
title Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma
title_full Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma
title_fullStr Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma
title_full_unstemmed Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma
title_short Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma
title_sort hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410176/
https://www.ncbi.nlm.nih.gov/pubmed/14970851
http://dx.doi.org/10.1038/sj.bjc.6601595
work_keys_str_mv AT mackierm hormonereplacementtherapyaftersurgeryforstage1or2cutaneousmelanoma
AT brayca hormonereplacementtherapyaftersurgeryforstage1or2cutaneousmelanoma

Ejemplares similares